European Life Sciences Key IT Deals and Initiatives Update, Q2 2022
This document provides IDC Health Insights’ overview of key IT deals, news, and digital initiatives in the European life sciences market in Q2 2022. This is the 16th document in a quarterly series of reports released by IDC Health Insights as it continues to provide in-depth research coverage of the European life sciences industry.
Please Note: Extended description available upon request.
- Executive Snapshot
- Situation Overview
- Expanding Pharma Beyond the Pill, Strengthening Patient Engagement
- Digital Therapeutics
- Smart Drug Delivery Systems
- Smart Shopping and Shipping, Pharmacy Omni-Experience
- Powering Precision Diagnostics, Expanding Med Tech Innovation and Services
- Digital Pathology
- Expanding Med Tech Services and Innovation
- Expediting R&D and Advancing Precision Medicine
- Trusted Research Environments and Collaborative Research Models
- AI-Based Drug Discovery and Design
- Solutions for Rare Disease Trials
- Digital Transformation Toward an Intelligent Life Sciences Enterprise
- Accelerating Digital Transformation
- Toward Pharma 4.0
- Customer Engagement
- Supporting Innovation Acceleration
- Key Mergers and Acquisitions
- Advice for the Technology Buyer
- Learn More
- Related Research
- Synopsis